ISOLATED HUMAN DRUGMETABOLIZING PROTEINS, NUCLEIC ACID MOLECULES ENCODING HUMAN DRUG-METABOLIZING PROTEINS, AND USES THEREOF

Details for Australian Patent Application No. 2002258549 (hide)

Owner PE CORPORATION (NY)

Inventors WEBSTER, Marion; WEI, Ming-Hui; DI FRANCESCO, Valentina; BEASLEY, Ellen, M.

Pub. Number AU-A-2002258549

PCT Pub. Number WO2002/077214

Priority 09/813,918 22.03.01 US

Filing date 19 March 2002

Wipo publication date 8 October 2002

International Classifications

C12N 009/00 Enzymes, e.g. ligases (6.)

C12N 015/00 Mutation or genetic engineering

C07H 021/04 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 009/10 Enzymes, e.g. ligases (6.) - Transferases (2.)

C12N 001/20 Micro-organisms, e.g. protozoa - Bacteria

Event Publications

27 March 2003 Application Open to Public Inspection

  Published as AU-A-2002258549

19 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002258550-Retinoid X receptor modulators

2002258548-IDENTIFICATION OF THE IKappaBNS PROTEIN AND ITS PRODUCTS